Previous 10 | Next 10 |
2024-06-21 11:20:50 ET Read the full article on Seeking Alpha For further details see: Stocks with the highest ROIC but not the highest valuation - Bernstein SG
2024-06-20 12:45:04 ET Summary Verona Pharma plc's ensifentrine has a PDUFA date on June 26th for COPD treatment, with promising Phase 3 study results suggesting the drug will secure commercial approval. Potential competition from Sanofi / Regeneron's Dupixent poses a threat, but ...
2024-06-20 10:00:19 ET Palm Beach, FL – June 20, 2024 – The National Cancer Institute’s (NCI) funding of research projects is predicted to empower the Pancreatic Cancer Market to grow. A report from Future Market Insights said that: “… the increa...
2024-06-18 03:42:39 ET Summary Moderna's RSV vaccine has been approved by the FDA, but it faces competition from GSK and PFE's offerings. A June 26 meeting of the Advisory Committee on Immunization Practices is a near-term catalyst. MRNA is hoping for parity with GSK/PFE when it c...
2024-06-17 11:30:03 ET Summary Amgen continues to delight investors with the growth in sales of its key blockbusters and the expansion of its portfolio of medications. In mid-June, Amgen pleased investors by announcing that the FDA had approved Blincyto to treat certain patients w...
2024-06-16 08:12:27 ET Summary In recent months, Incyte's management has continued to delight investors by accelerating the pace of development of its anti-inflammatory treatments. On May 30, 2024, Incyte announced the completion of its acquisition of Escient Pharmaceuticals for $...
2024-06-14 10:59:33 ET More on bird flu CSL Seqirus to provide more than 40M bird flu vaccine doses to Europe Virax surges amid bird flu concerns Bird flu death in Mexico linked to strain not seen in humans before Third human bird flu case found...
2024-06-13 02:30:42 ET Summary A difficult period for Pfizer might be coming to an end, as serious setbacks and tough Y/Y comps are in the rearview mirror. The first quarter performance of the commercial business exceeded Street expectations, and the company maintained its full-ye...
2024-06-11 07:23:55 ET More on GSK GSK plc: Long-Term Cash Cow GSK Breathes New Life Into Asthma Treatment With Depemokimab GSK plc (GSK) Q1 2024 Earnings Call Transcript GSK, SpringWorks end collaboration agreement GSK wins FDA nod to expand label fo...
2024-06-10 14:58:39 ET More on CSL, bird flu Bird flu death in Mexico linked to strain not seen in humans before Travere, CSL win conditional nod for kidney disease therapy in EU Seeking Alpha’s Quant Rating on CSL Historical earnings data for CSL ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 08:30:06 ET Jefferies analyst issues BUY recommendation for GSK on July 2, 2024 06:21AM ET. The previous analyst recommendation was Buy. GSK was trading at $38.38 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst ...
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes 1 Clinical development program continues to evaluate safety and immunogenicity in adults 18+ with data read-outs expected H2 2024 GSK plc (LSE/NYSE: GSK) today an...
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response New treatment options are needed for patients facing negative impacts to quality-of-life with current standard of care Additional registrational ...